Poster Abstract Session:
72. TB: Multidrug Resistant TB
Thursday, October 8, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: HIV-STD-TB, Global ID, Adult ID

Presentations:
568
A Pilot Study on Epidemiology of Drug Resistant Tuberculosis Among in Sub-Himalayan Valley of Himachal Pradesh, India – A Large Unmet Gap
Shubhanker Mitra, MD - Medicine ; Pradeep Zechariah, MBBS ; Philip Alexander, MS - Surgery ; Anna Alexander, MD - Medicine
569
MDR-TB Treatment as Prevention: Modeling the Population-Level Impact of Expanded Treatment for Multidrug-Resistant Tuberculosis
Emily Kendall, MD ; Andrew Azman, PhD ; Frank Cobelens, MD, PhD ; David Dowdy, MD, PhD
Posters
  • IDWeek poster 201510 EAKendall MDR-TB Treatment as Prevention.pdf (702.4 kB)
    • 570
    Diabetes reduces the rate of sputum culture conversion in patients with primary multidrug resistant tuberculosis
    Argita Salindri, MPH ; Maia Kipiani, MD ; Russell R Kempker, MD ; Neel Gandhi, MD ; Lasha Darchia, MD ; Nestani Tukvadze, MD ; Henry Blumberg, MD, FIDSA, FSHEA ; Matthew Magee, Ph.D.
    Posters
  • Salindri et al., Abstract #53031 Poster Presentation #570 .pdf (532.4 kB)
    • 571
    Clinical impact of rpoB mutations conferring discordant phenotypic-genotypic rifampin resistance in Mycobacterium tuberculosis
    Neha Shah, MD MPH ; Grace Lin, MS ; Pennan Barry, MD, MPH ; Gisela Schecter, MD, MPH ; Ed Desmond, PhD
    Posters
  • ID week 2015 rpoB discordant v2.pdf (721.6 kB)
    • 572
    Clinical Relevance of Routine Pyrazinamide Drug Susceptibility Testing in Multidrug-Resistant Tuberculosis
    Gustavo E. Velásquez, M.D., M.P.H. ; Roger I. Calderon, Laboratory Director ; Carole D. Mitnick, Sc.D. ; Mercedes C. Becerra, Sc.D. ; Zibiao Zhang, Programmer/Analyst ; Carmen C. Contreras, Sub-Director of Research Projects ; Rosa M. Yataco, Data Coordinator ; Jerome T. Galea, Ph.D., M.S.W. ; Leonid W. Lecca, M.D. ; Megan B. Murray, MD, MPH, ScD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.